Ignite Creation Date:
2024-05-06 @ 3:28 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04645966
Status:
TERMINATED
Last Update Posted:
2024-03-25
First Post:
2020-11-20
Brief Title:
A Clinical Trial to Assess the Safety Tolerability and Immunogenicity of MenABCWY in Healthy Infants
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A PHASE 2b TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MenABCWY IN HEALTHY INFANTS 2 AND 6 MONTHS OF AGE
Status:
TERMINATED
Status Verified Date:
2023-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
The Sponsor decided to discontinue the study based on Sponsors careful review of available safety data in concert with the recommendation of an independent Data Monitoring Committee
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the study is to describe the safety tolerability and immunogenicity of MenABCWY in healthy infants 2 and 6 months of age
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2020-000948-60 | EUDRACT_NUMBER | None | None |